Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: United States Clear all

289 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200018
200112
200218
200314
200414
200520
200618
200718
200816
20096
20107
201110
20127
20138
20146
20155
20165
20179
20186
20195
20207
20215
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed289

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center36
National Cancer Institute (NCI)17
Case Comprehensive Cancer Center16
Memorial Sloan Kettering Cancer Center16
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins14
Incyte Corporation9
M.D. Anderson Cancer Center8
City of Hope Medical Center7
Northwestern University7
Roswell Park Cancer Institute7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders289
Myelodysplastic Syndromes182
Leukemia, Myeloid, Acute171
Precursor Cell Lymphoblastic Leukemia-Lymphoma160
Leukemia150
Leukemia, Lymphocytic, Chronic, B-Cell141
Primary Myelofibrosis133
Leukemia, Myelomonocytic, Chronic132
Multiple Myeloma130
Hodgkin Disease129

Trials

Showing 1 to 25 of 289. Each trial links to its page on Pharma Observatory.

189 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.